Cover Image

Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease?

Saved in:

Bibliographic Details
Main Author:	Claude P. Muller (Author)
Format:	Book
Published:	Elsevier, 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
by: Miquel Oliu-Barton, PhD, et al.
Published: (2022)

Do asymptomatic carriers of SARS-COV-2 transmit the virus?
by: Claude P. Muller
Published: (2021)

Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection
by: Catherine Chen, et al.
Published: (2021)

Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
by: Chao Zhang, et al.
Published: (2020)

Cyclophilin A‐mediated mitigation of coronavirus SARS‐CoV‐2
by: Simranjeet Singh Sekhon, et al.
Published: (2023)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021)

On the role of financial support programs in mitigating the SARS-CoV-2 spread in Brazil
by: Vinicius V. L. Albani, et al.
Published: (2022)

Incidence and severity of SARS-CoV-2 virus post COVID-19 vaccination: A cross-sectional study in India
by: Preethi Selvaraj, et al.
Published: (2022)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest
by: Hayden L. Smith, et al.
Published: (2021)

Mitigating SARS-CoV-2 Transmission in Hospitals: A Systematic Literature Review
by: Chester Yan Hao Ng, et al.
Published: (2022)

Chinese parents' intentions to vaccinate their children against SARS-CoV-2 infection and vaccine preferences
by: Yulan Lin, et al.
Published: (2021)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
by: Lianlian Bian, et al.
Published: (2022)

BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?
by: Siya Kamat, et al.
Published: (2020)

Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2
by: Iman Almansour, et al.
Published: (2021)

Can Asymptomatic or Non-Severe SARS-CoV-2 Infection Cause Medium-Term Pulmonary Sequelae in Children?
by: Ilaria Bottino, et al.
Published: (2021)

Neurovascular Adverse Effects of Sars-Cov-2 Vaccination
by: Panos LD, et al.
Published: (2024)

Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection
by: John T. Bates, et al.
Published: (2024)

Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
by: Haruka Maeda, et al.
Published: (2024)

Durability of COVID-19 humoral immunity post infection and different SARS-COV-2 vaccines
by: Fayhan Alroqi, et al.
Published: (2024)

Natural and vaccine-induced immunity are equivalent for the protection against SARS-CoV-2 infection
by: Matteo Franchi, et al.
Published: (2023)

Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
by: Hong-Zhi Chen, et al.
Published: (2020)

Long-term observation of antibody titers against SARS-CoV-2 following vaccination
by: Kazuo Sugiyama, et al.
Published: (2022)

DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
by: Kit Man Chai, et al.
Published: (2021)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Sensitivity analysis of SARS-CoV-2 aerosol exposure
by: Redder, Christian, et al.
Published: (2021)

Can Robots Improve Testing Capacity for SARS-CoV-2?
by: Cresswell, Kathrin, et al.
Published: (2020)

Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the SARS-CoV-2 Omicron BA.1 and BA.2 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
by: Haruka Maeda, et al.
Published: (2023)

Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy
by: Gaurav Joshi, et al.
Published: (2022)

Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications
by: Mária Orendáčová, et al.
Published: (2022)

Morphea after SARS-CoV2 vaccine
by: Giovanni Paolino, et al.
Published: (2023)

T cells in SARS-CoV-2 infection and vaccination
by: Arthur Young
Published: (2022)

SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil
by: Karoline Rodrigues Campos, et al.
Published: (2021)

Vaccine safety - is the SARS-CoV-2 vaccine any different?
by: Noam Tau, et al.
Published: (2021)

Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
by: Kumaragurubaran Karthik, et al.
Published: (2020)

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
by: Yuntao Zou, et al.
Published: (2022)

Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
by: Isaac Yeboah Addo, et al.
Published: (2022)

A systematic review of current status and challenges of vaccinating children against SARS-CoV-2
by: Mengxin Zhang, et al.
Published: (2022)

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
by: Elias Tayar, et al.
Published: (2023)

Correction: DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
by: Kit Man Chai, et al.
Published: (2023)

Efficacy of vaccination against the SARS-CoV-2 virus in patients with chronic kidney disease on hemodialysis
by: María E. Sanhueza, et al.
Published: (2023)